IPEX Syndrome Latest Advances

Find the Latest Research About IPEX Syndrome

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications

Case Report: Effective IL-4/IL-13 axis suppression and resolution of severe atopic dermatitis by dupilumab monotherapy in a patient with IPEX syndrome.

Case Report: Effective IL-4/IL-13 axis suppression and resolution of severe atopic dermatitis by dupilumab monotherapy in a patient with IPEX syndrome.

Journal: Frontiers in immunology
Published: June 29, 2026

FOXP3 Mutations and Instability as Determinants of Regulatory T-Cell Plasticity in Endocrine Autoimmunity.

FOXP3 Mutations and Instability as Determinants of Regulatory T-Cell Plasticity in Endocrine Autoimmunity.

Journal: International journal of molecular sciences
Published: May 09, 2026

X-Linked immune dysregulation, polyendocrinopathy, and enteropathy (IPEX) syndrome with concurrent membranous and IgA nephropathy: a case report.

X-Linked immune dysregulation, polyendocrinopathy, and enteropathy (IPEX) syndrome with concurrent membranous and IgA nephropathy: a case report.

Journal: BMC nephrology
Published: February 10, 2026

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.

Journal: Journal of clinical immunology
Published: September 01, 2025

Immune Dysregulation, Polyendocrinopathy and Enteropathy X-Linked Syndrome with Neonatal Onset: A Case Report.

Immune Dysregulation, Polyendocrinopathy and Enteropathy X-Linked Syndrome with Neonatal Onset: A Case Report.

Journal: Acta medica portuguesa
Published: August 08, 2025

Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Journal: Frontiers in immunology
Published: July 05, 2025

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 27, 2025

The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients.

The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients.

Journal: Journal of clinical immunology
Published: February 13, 2025

Cyclophosphamide post-haploidentical stem cell transplantation experience in an infant with IPEX syndrome

Cyclophosphamide post-haploidentical stem cell transplantation experience in an infant with IPEX syndrome

Journal: Biomedica : revista del Instituto Nacional de Salud
Published: November 28, 2024

Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients.

Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients.

Journal: Journal of clinical immunology
Published: October 31, 2024

Expanding the spectrum of IPEX: from new clinical findings to novel treatments.

Expanding the spectrum of IPEX: from new clinical findings to novel treatments.

Journal: Current opinion in allergy and clinical immunology
Published: October 30, 2024

Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.

Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.

Journal: Journal of clinical immunology
Published: July 08, 2024
Showing 1-12 of 128

Last Updated: 09/19/2026